Analysis

Test-Makers See Way Out Of FDA Rule With Chevron Reversal

By Mark Payne · August 13, 2024, 8:08 PM EDT

This spring, despite widespread industry opposition, the U.S. Food and Drug Administration granted itself oversight of laboratory-developed diagnostic tests. Now, industry groups say they're facing a costly and convoluted agency approval...

To view the full article, register now.